SkinnyRx
US$ 28.05
soul trial oral semaglutide cardiovascular outcomes 2024 results nejm Reduces CV Events in T2DM β (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine π§ͺ T2DM + ASCVD/CKD π Oral semaglutide 14 mg vs placebo π The Role of Glucagon-Like Peptide-1
Description
And Amber, thank you so much
While Semaglutide's primary use is for managing diabetes, it has been found to have significant effects on weight loss
In this study, there was no meaningful difference in the amount of weight lost based on the type of bariatric surgery that had been performed
Fibromyalgia patients often have heightened sensory sensitivity, which can include gastrointestinal sensitivity
Vidal, T
Safety Considerations and Side Effects GLP-1 agonists are generally well-tolerated, with common side effects including nausea, vomiting, and diarrhea, especially during the initial stages of treatment
